MCQ 2549-2551

PQ 191 Rx CU 65 et al.

1.
2.

3.

4.

**

MCQ (
MCQ OSPE) **

MCQ 2549 case 2 10 case

2 20 case case 15 300

MCQ 2549 case 2 15

case 2 30 case case 10 300

4 A,B,C,D (

1
()

 case
:

:
4:3:3 ( 2551)

()

..

- , , , (), (),
( ), , , New Light
(), (USA)
5
-

 2549
( 1)

1


:

1.

a. ( tuberculosis)
b. (pneumonia)
c. (gonorrhoea)

d. (candidosis)
e. ( HIV)

2.

a. Abacavir
b. Ritonavir

c. Nevirapine
d. Lamivudine
e. Diravirdine

6.

a. Cotrimazole
b. Nystatin

c. Claritromycin

7.

1. zidovudine 100 mg 2. ritonavir

3. azithromycin tab 150 mg 4.

rifampicin

3. GPOvir

a. Zidovudine + Didanosine +

1. zidovudine

Ritronavir

b. Stavudine + Lamivudine +
Saquinavir

c. Stavudine + Lamivudine

+Nevirapine

4.

3.azithromycin

5.

lipodystrophy

4. rifampicin
2. ritonavir

 zidovudine
8.

a.

Inhibit protein synthesis

b.

Inhibit HIV protease

c.

Inhibit HIV reverse transcriptase

e.

Inhibit cell wall synthesis

d.

11.

Inhibit thymidine kinase

c. Gonorrhea

9. Ritronavir

b.

....

c.

d. Herpes genitalis

e. Trichomoniasis
12.

a. Tinidazole
single dose

basic functionality

b. Metronidazole

ionize
e.

single dose

polar functionality

c. Clotrimazole

10. Rifampin

d. Ciprofloxacin

e. Cotrimoxazole

a. air oxidation
hydrozone

c.

d.
e.

2 24

white sugar-coated tablet

b. hydrolysis

peptide-like ...
d.

a. Bacterial vaginosis
b. Candidiasis

a.

13.

a. Tetracyclin 250

mg

b.
3

c.
d.

e.

14.

e.
19.

a.

b.
c. 8-15

a. Case control

d.

b. Randomized control study

e. 2g

15.

c. Case

a. Natural fat base

d. Analysis of secular trend

20.

b. Synthetic fat base

c. Water soluble base

d. Emulsion base

Vanotab

e. Absorption base
16.

a. Clotrimazole

b. Cotrimoxazole

c. Itraconazole
17.
18.

d. Metronidazole

a.

2x2pc 1

20

70%

90%

Vanotab

1 OD 1

b.

a. 90

d.

c. 100

c.

b. 98

d. 103

b. Diazepam

e. 110

c. Vigabutrin

3 32

d. Carbamazepine

Partial seizure secondarily to

generalized tonic-clonic seizure

e. Gabapentin
23.

Phenytoin

Phenytoin sodium (100mg)

a. Glugival hyperplasia

c. Rash

3 capsule hs

b. Hepatitis
d. Ataxia

Phenytoin
28 mg/L (

Phenytoin
10-20 mg/L)
21.

a.

b.

c.

d.
..

e.

2

22.
Phenytoin Sodium

a. Ethosuximide

24.

e. Hyponatremia

a. Phenytoin
b. Valproate

c. Phenobarbital

d. Carbamazepine
25.

phenytoin phenytoin
a. Erythromycin
b. Cimetidine

c. Conjugated estrogen
26. phenytoin

a. Lactose

b. Dextrose

c. Calcium sulfate
d. Pregelatinized starch

e. Microcrystalline cellulose
27.

phenytoin

a. Crospovidone
b. Croscarmellose

c. Sodium lauryl sulphate

d. Sodium starch glycolate

e. Colloidal silicone dioxide

b.
c.

d.
e.

4 50

Non-Small Cell

Lung Cancer (NSCLC) Satge IV

Cisplatin 100 mg/m IV drop over

1 hour on day 1

28.

29. phenytoin

a. infrared spectroscopy (IR)

Benzene

b. infrared spectroscopy (IR)

secondary amide

c. infrared spectroscopy (IR)

carbonyl

d. ultraviolet spectrometry

(UV) Benzene

e. ultraviolet spectrometry

Etoposide 100 mg/m IV drip over

1 hour on day 1,2

60 kg. 180 cm
2

Surface area= 1.73 m

31. Cisplatin

a. 150
b. 175
c. 200
d. 225
e. 250

(UV) secondary
amide

30.
......2540

Phenytoin

a.

32.

Acute Emetic

a. Ondansetron
b. Dexamethasone

c. Metoclopramide
d. Ondansetron +

48 hours

e. Metoclopramide +

8 hours

Dexamethasone
Dexamethasone

Cisplatin
33.

a. Akylating agent

0.6 - 0.41 mg/ml

1.0 - 0.61 mg/ml

2 hours

manufacturer does not recommended

administration at conc. more than 0.4

d. Intercalating agent

time to precipitation

e. Inhibitor of mitosis

mg/ml due to highly unpredictable

etoposide

34. Cisplatin

(Nephrotoxicity)

(100 mg/m )

D5W 500 ml

a.

a. 96 .

b. 48 .

b.

Magnesium

c. 8 .

c. Osmotic diuretic

d. 2 .

Mannitol

e.

d. Cisplatin

Sodium chloride

35. etoposide
stability

At temperature in D5W or NS in

polyvinyl
hours

b. Topoisomerase II inhibitor

c. Antimetabolite

0.4 - 0.21 mg/ml

0.2 mg/ml

96

36.

a.

b.

.....

c.

d.

a. A hydrophobic

medium

e. ()

b. B hydrophilic medium

c. C hydrophobic

medium

37. Cisplatin

d. B

a. Doxorubicin

e. C

b. Cytarabine
c. Melphalan

40.

d. Carboplatin

+
++
++

a. Clean room class 100,000

b. Clean room class 10,000

+ +
+- +
+ +
- -+ - +
-+
+ +

c. Clean room class 1,000

d. Horizontal laminar airflow

hood

a. Diffusion controlled

b. Dissolution controlled
c. Erosion controlled

d. Osmotic controlled
e. Ion exchange controlled
39.

e. Metrotrexate
38.

e. Biological safety cabinet

5 53

5
3-4


BP 138/88 mmHg HR 85 RR

18/min
Total cholesterol (<240)

mg/dL

243

Triglyceride (<200)

200 mg/dL

HDL- C (>40)

33mg/dL

FBS (<126)

135 mg%

HbA1c (<7)

7.0%

Myocardial infarction 53
44

Glibencarmide 10 mg BID
41. LDL- C

a. 130 mg/dl
b. 140 mg/dl
c. 150 mg/dl
d. 160 mg/dl

e. 170 mg/dl
42. major risk factor

Coronary heart disease

a.

Myocardial infarction
53

b.

Myocardial infarction
44

c.

d.

HDL-C 33 mg/dl

e.

53
43.

Hyperlipidemia

a. Total cholesterol
b. Triglyceride
c. HDL-C
d. LDL-C

e. Non-HDL-C
44. LDL

C
atherosclerosis
a.

< 100 mg/dl

b. < 130 mg/dl

c. < 160 mg/dl
d. < 190 mg/dl

e. < 200 mg/dl

45.

a. Statin

b. bile acid segvegtrants

c. nicotinic acid
d. fibric acid

e. plant sterols

sitosterol campesterol

46. Statin LDL-

a. LDL-C receptor

b. cholesterol
LDL-C receptor

c. enterohepatic recycling
cholesterol

d. VLDL
e. HDL

lactone ring
carboxylic acid

d. Simvastatin

Simvastatin
Pravastatin
47.

a. Cholestyramine

Simvastatin Simvastatin
lactone ring

b. Cholestyramine

Pravastatin Pravastatin

carboxylic acid
c. Simvastatin

Cholestyramine

d. Cholestyramine
Simvastatin

Provastatin

e. Cholestyramine

Simvastatin Provastatin
48.

a. Pravastatin prodrug
b. Simvastatin Pravastatin
prodrug

c. Pravastatin
2

lactone ring

e. Simvastatin Pravastatin
prodrug
49.

Drug use statin

a.

b.
c.

d. ...
e.

50.

statin ....

a. Cohort study , Case

controlled study

b. Case report, Cross-sectional

study

c. Case controlled study, Cross-

sectional study

d. Meta-analysis, Randomized
controlled study

e. Cross-sectional study,

c.

Randomized controlled study

6 25
10
Salbutamol MDI

attack 2-4 puffs

d.

e.

51.

a.
b.

bioavailability

54. 2

a. Inhaled fenoterol (100mcg/puff)
3 puffs

Zileuton (600mg/tablet)

b.

c.

d.

1 4

c. Sustained-released theophylline

(200mg) 1 2

e.

52.

a.

b.

c.
d.
e.

Inhaled budesonide (200

d.

mcg/puff) 2 puffs 2

e. Ketotifen (1mg/tablet) 1
2

55.

53. Salbutamol

MDI

a. long-acting beta 2

antagonist

b.

inhaled steroid

steroid

a. Inhaled Salmeterol DPI (50

mcg/blister) 1 blister
12 .

Inhaled Cromolyn MDI

b.

(1mg/puff) 2 puff 3

c. Inhaled Fluticasone DPI (250

mcg/inhalation) 2
inhalation 3

Prednisolone (5 mg/tab)

d.

e. Inhaled Ipratopium MDI (18

mcg/puff) 2 puff 3

56.

steroid
a. Sore throat

b. Pharyngitis

c. Metallic taste

d. Gingivitis

e. Oral thrush
57.

Theophylline

a. Ciprofloxacin
b. Fluvexamine
c. Cimetidine

d. Amoxicillin
e. Rifampicin

58. inhaler device

a. spacer
Metered Dose

Inhaler (MDI)

oral

thrash
b.

Nebulizer

c. Dry powder Inhaler

(DPI) ...
10

d. breath activated

device

e. Turbuhaler




59.

a. Turbutaline (2.5mg/tab)
b. Prednisolone (5mg/tab)
c. Inhaled fermoterol (4.5
mcg/dose)

d. Inhaled beclomethasone (250

mcg/puff)

e. Theophylline (200 mg
sustained-release)

60. Evohaler

a. metered dose inhaler

b. propellant

c.

c. propellant non-CFC

d. 1

d.

e.

7 33

e.

64.

a.

b.

c.

d.

61.

a. Prednisolone

e.
65.

a. Senna

b. Hydrocortisone, cimetidine

b. Castor oil

c. Hyossacine HCl, Zinc oxide

c. Bisacodyl

62.

d. Lactulose

a. Senna

b. Castor oil
c. Bisacodyl

d. Mineral oil
e. Phylium seed
63.

a. 6

b.

66.

e. Phylium seed

a.

b.
c.

d.

e.

15

67.

2g
0.3g Displacement

valve = 1.5 base

a. 155 g
b. 175 g
c. 180 g

d. 197 g
e. 200 g
68.

15

a. Calcium carbonate

b. Potassium chloride
c. Sodium bicarbonate

d. Potassium lichromate
e. Potassium permanganate
69.

.....
15 3

a.

b.

c.

d.

e.

70.

a.

b.

c.

d.

e.

8 60
48 kg 170 cm

c. Furosemide

d. Amiloride

Blood urea nitrogen = 60 mg/dl

(normal 7-20 mg/dl)

Serum creatinine concentration = 3

mg/dl (normal 0.5-1.4 mg/dl)

e. Indapamide
74.

a.

Serum potassium concentration =

b. renal shut down

6.5 mEq/l (normal 3.5-5.2 mEq/l)

c.

5 creatinine

d. -

clearance 18 ml/min

e.

71.
Creatinine clearance

acidosis

a. Acute renal failure

b. Renal insufficiency
c. Chronic renal failure
d. Uremia

e. End-state renal failure

72.

hyperkalemia
a. Potassium chloride
b. Sodium chloride

c. Sodium polystyrene sulfonate

d. Calcium chloride

e. Calcium phosphate
73.

a. Hydrochlorothiazide
b. Spironolactone

sodium bicarbonate bicarbonate

2.8 mmol/l sterile water for injection

100 ml

75.
sodium

bicarbonate
sodium bicarbonate
5 ml 2 mg/ml

(Mw Na=23, H=1, C=12,

O=16)

a. 2 Amp
b. 3 Amp
c. 4 Amp
d. 5 Amp
e. 6 Amp

79. A

76.

a. Clean room class 10

b. Clean room class 100

c. Clean room class 1000

diuretic .......

HCTZ

a. Case control

d. Clean room class 10,000

b. Cohort

e. Clean room class 100,000

77.

c. Meta-analysis of case control

studies

a. Sterility

d. Deseriptive

b. Osmolarity

e. Randomized control trial

c. Microbial limit test

d. Particulate matter

80.

a.

e. Preservative

b.

78.
Sodium bicarbonate

c.

e.

d.

injection
a.
b.

50,000

c.

d.
50,000

e.

generalized anxiety disorder

6

81.

a. Lithium carvonate
b. Clozapine

c. Chlorpromazine
d. Haloperidol

e. Diazepam

b. Elomipramine

82. fluoxetine

c. Amitriptyline

a.

d. Doxepin

b.

c.

d.
....

e.

83.

major depressive disorder

e. Sertraline

85. antidepressant

a.

b.

2-3

c.

d.

a. Venlafaxine

b. Paroxetine

c. Amitriptyline
d. Bupropion
e. Sertraline
84.

a. Imipramine

e.

86.
benzodiazepine

a.

b. Triazolam

25%

c. Olanzapine

75%

89.

a. matrix

b. osmotic

d.

c.

25%

e.

1

87.

d. matrix
90.

( bulking agent)
( disintegrant )

a. Lactose

b. Magnesium sulfate

c. Microcrystalline cellulose

a.

d. Corn starch

b.
c.

d.
e.

88. Risperidone


methanol

HCl 0.1 normal

a. Shellac

b. Cellulose acetate phthalate

c. Hydroxypropyl

methylcellulose

d. Polyvinyl acetate phthalate

e. Polyvinyl pyrroridone

e. Sodium lauryl sulfate

10 28

Thyroid stimulating hormone (TSH)

91.

Thyroxine

a. Goiter, constipation, lethargy,

dry skin

b. Goiter, depression, puffy face,

lethargy

c. Goiter, cold intolerance,

decreased sweating,
bradycardia

d. Goiter, loose bowels,

insomnia, irritability

e. Goiter, fatigue, weight gain,

decreased appetite

Propanolol 20 mg QID for 3 weeks

Propylthiouracil 100 mg TID for 6
weeks

2
1

cuthyroidal state

92. Propylthiouracil
2542

a.
b.

methimazole

b.

Propylthiouracil

c.

d.
iodine

e. propranolol

propylthiouracil

94.

thiouracil

a.
b.
c.

d. SLE like syndrome

e. Metallic taste

95. Propylthiouracil

b. thyroid

c.
d.

e.

drug use evaluation

93.

a. Propylthiouracil

a. thiourea

hormone

c.
hypothyroid

d. thyroid

peroxidase

e. T3
96. Propylthiouracil: White, crystalline

sub that has a bit ?? water

 ... 50 mg

conjagation carbimazole

d.
amide

hydrolysis

methimazole

carbimazole

e.
ester hydrolysis
carbimazole

carbimazole

97. propanolol
propylthiouracil

a. Propanolol alpha-

p
ropylthiouracil

methimazole,

carbimazole propylthiouracil

a. methimazole, carbimazole

propylthiouracil

metabolized
desulfunation

b. propylthiouracil

metabolized

dealkylation Propyl
group

c. methimazole

metabolized

adrenergic blocking agent

b. Propanolol
tremor tarchycardia
thyrotoxicosis

c. Propanolol

pharmacokinetic

propylthiouracil
propylthiouracil

d. Propanolol
propylthiouracil

e. Propanolol

propylthiouracil
T4

98. goiter

a. Ion thiocyanate
goiter

b. Thiocyanate

metabolize ...

c. Lithium secretion
Thyroxine

thiiodothyroxine
hyperthyroidism

e. Propylthiouracil
11 55

estradiol

valerate 2 mg + norgestrel 0.5 mg

101.

a.

d. Goitrin thyroid

peroxidase

b.

e. Percholate ion

uptake iodide

c.

iodide thyroid

99. toxic goiter

d.

a.
iodine

e.

b. iodine

c.

d.

e. thiocyanide

100.

Lugols solution

a. Iodine + KI
b. Manganese

c. Methimazole
d. Thiocyanate

102.

(transdermal patch)

a. first

pass metabolism

b.

c.

d.

d.
partition

e.
osteoperosis

103.

coefficient 1

e. therapeutic index

a. estradiol valerate 2 mg +

norgestrel 0.5 mg

b. medroxyprogesterone acetate
5 mg

106.

a.

c. ethimylestradiol 30 mcg +

b.

cypoterone acetate 2 mg

c.

d. conjugated estrogen 0.625

d.

mg

e.

e. conjugated estrogen 0.625

mg + medroxyprogesterone 5
mg
104.

spectrum

107.

phytoestrogen

103

a. Hyperlipidemia
b. Osteoperosis

c. Hyperbilirubinemia
d. Congestive heart failure

a. UV-visible spectrophotometer

e. Thromboembolism
105.

b.

c.

Transdermal

b.
c.

H-NMR spectrometer

13

C-NMR spectrometer

d. FT-IR spectro

a.

e. Mass spectrometer
108.

a. B1-6-12 tablet

b. Doxycyclin capsule
c. Senna tablet
d. Antacid gel

SLE

a.

e. Premarin 0.625 mg
109.

111.

hydrazine

Lupus

b. sunscreen SPF 15

a. Ibuprofen 400 mg

c.

b. Dexamethasone 0.5 mg

c. Indomethazin 25 mg

d.

d. Piroxicam 10 mg

hydralazine chorpropamide

e. Celebrex 200 mg
110.

anticonvulsant

lupus

e.

a. Diazepam 10 mg

b. Diclofenac inj 75 mg
c. Methadone tab 10 mg

d. Pentazocine tab 25 mg

topical steroid topical steroid

a. Hydrocarbon base

e. Voltaren SR tab 100 mg

b. Oleaginous base

12 22

c. Absorption base

d. O/W emulsion base

e. W/O emulsion base

2





Systemic Lupus

Erythematosus (SLE)

112.

113.

Topical steroid

a. Psuedoplastic flow
b. Psuedoplastic flow with

thixotropy

c. Dilantant flow with

c. Product C

thixotropy

d.

d. Antithixotropy

e.

e. Newtonium flow

SLE

116.

(rate

constant, K) aspirin tab

hydroxychloroquin 200 mg

114.

a. (slope)

b.

(slope)

a. Ocular examination

c. Intercept

b. Chest x-ray

d. Intercept

c. Liver function test

e. Intercept slope

d. Urinalysis

e. EKG

aspirin

117.

aspirin tab

a. (half life)

115.

aspirin

aspirin tab

b. (shelf life)

c. . aspirin

aspirin

aspirin

Product A

d. . aspirin

Product B

Product C

e. aspirin

first order rxn

Aspirin tab

a. Product A
b. Product B

118.

steroid cytotoxic

drug
TB
Isoniazid,

Rifampin, Pyrazinamide,

e.

Ethambutol
SLE

a. Isoniazid

120.

amcinonide

prednisolone

b. Rifampin
c. Pyrazinamide
d. Ethambutol

e. Pyrazinamide

amcinonide

Ethambutol

119.

Prednisolone

Dexamethasone

a. Dexamethasone
steroid

short acting steroid

b. Dexamethasone
steroid

long acting steroid

c. equivalent dose

Potency

d.

Prednisolone

glucocorticoid
dexamethasone
mineralocorticoid

prednisolone
a.

Pregnane

b. Amcinonide antiinflamatory

activity prednisolone

c. Amcinonide lipophilicity
prednisolone

d. Amcinonide salt water

retention prednisolone

e. Amcinonide

9-F 11-OH

amcinonide glucocorticoid
activity prednisolone
13 45

1

paracetamol

121.

e. Tramadol
125.

a. Corticosteroid

b. Xanthine oxidase inhibitor

a. Rheumatoid arthritis

c. Uricosuric agent

b. Osteoarthritis

d. NSAID

c. Osteoporosis
d. Acute gout

e. Osteomalacia

122.

a. Paracetamol
b. Probenacid
c. Colchicine
d. Tramadol

e. Allopurinol
123.

e. Para-aminophenol derivatives
126.

Rx

% labeled amount
60

. .. 2510

a.

b.
c.

a.

d.

b.

127.

c. Efervessant tablet

d. Filmed coated tablet

b. Indomethacin
c. Allopurinol

d. Paracetamol

b. Enteric coated tablet

a. Prednisolone

e.
a. Uncoated tablet

e.
124.

Diclofenac 25 mg # 30

d.

Sig: 2 tab p.o. tid pc

c.

e. Sugar coated tablet

128.

(enteric coated tab)

a.

b.

b. Staphylococcus epidermidis

c.

c. Streptococcus pnuemoniae

e.

e. Chlamydia tracamatis

d.

129.

d. Neisseria gonorrheae
132.

a. Dexamethazone eye drop

a. Celecoxib

b. Oxymethazoline eye drop

b. Tramadol

c. Meloxicam

d. Prednisolone
130.

133.

b.

c. RNA

a.

d. leucocytes

b.

d.
2

134.

a. 25c 6-8 week

b. 25c 3-4 week

c. 2-8c 6-8 week

14 19

d. 2-8c 3-4 week

131.

a. Staphylococcus aureus

e. cell wall

...

e.

a. DNA

c. Idoxuridine eye drop

e. Indomethacine

c.

e. 8-15c 3-4 week

135.

C-3 hemisuccinoyl

ester

b. pH pKa

c.

ester

d. cosolvent

C-3 hemisuccinoyl ester

e. lyophilized

a.

b.

c.

d.

powder

138.

a. clay

b. polysaccharide

e.

c. cellulose

136.

d. hydrated silicate

e. colloidal silicone

2% A 180 ml

isotonicity
(Freezing point
= -0.52

c, freezing point

A 1% = -0.12 c, freezing point

= -0.58

c)

a. 0.28%
b. 0.38%
c. 0.48%
d. 0.58%
e. 0.68%
137.

hydrolysis

A

a. complexing agent

dioxide
139.

140.

polymycin B sulfate

10,000 units/ml 12

.. 2548
8,500 units/ml

a.

b.

c.
d.
e.

15 25

(greasy scale)
nasolabial folds

 10

valerate < 0.05%

betamethasone dipropionate

c. 0.05% betamethasone

psoriasis
141.

dipropionate < 0.05%

clobetasone propionate <

0.1% betamethasone valerate

a. Contact dermatitis

d. 0.1% betamethasone valerate

b. Psoriasis

< 0.1% triamcinolone

c. Saborrheic dermatitis

acetonide < 0.05%

d. Dandruff
142.

clobetasone propionate

e. Tinea vesicolor

e. 0.05% clobetasone propionate

< 0.1% betamethasone

valerate < 0.1% triamcinolone

a. Selenium sulfide shampoo

acetonide

b. Tar shampoo

c. Salicylic acid

d. Topical steroid
e. Ketoconazole shampoo
143.

144.

a. Ketoconazole shampoo

topical

12

steroids

b. Dandruff

topical

Topical corticosteroid

steroids

c. Sulfur keratolytic

agent

a. 0.1% betamethasone valerate

d. coal tar

< 0.05% betamethasone

photosensitivity

dipropionate < 0.05%

e. Selenium sulfide

clobetasone propionate

hyperproliferation cell

b. 0.05% clobetasone propionate

< 0.1% betamethasone

145.

ointment each g contains:

Betamethasone 0.5 mg and salicylic

acid 30 mg in a paraben freez

d. High performance liquid

ointment base of white petroleum

chromatography

and mineral oil ointment

e. High performance thin layer

base
a. water soluble ointment base
b. oleaginous ointment base
c. emulsion ointment base

d. absorption ointment base

chromatography
148.

Reg. no. 2C802/45

a.

e. acidic ointment base

146.

..2545

b. 8

salicylic acid

.. 2545

a.

c.

8 .. 2545

b.

d.

..2545

phospholipase A2

e.

c.

Keratolytic agent

d.
antioxidant
e.

8 .. 2545

149.

a. 1
b. 2
c. 3

d. 4

Ketoconazole

e. 5

a. Gas chromatography

b. UV/visible spectrophotometer
c. IR spectroscopy

(Reg. no. 2C802/45)

emulsifying agent

147.

150.

a. Coal tar shampoo

b. Dexamethasone cream
c. Betamethasone + salicylic
ointment

d. Hydroxyzine tablet 25 mg
e. Methotrexate tab 2.5 mg

2549
( 2)
1 44

. Norfloxacin

. Ciprofloxacin

penicillin

1.

. Erytromycin

. Chloramphenical

. Amoxycillin
2.

10 penicillin
( anaphylaxis )

( randomized parallel)

. ( cohort

. Erytromycin

study design)

. Levofloxacin

. Chloramphenical

( single binded design )

. Azithromycin
. Amoxycillin

3.

. Tetracyclin

6.

. Erytromycin

. Dicloxacillin
. Cotrimazole

. Amoxycillin

4.

. .. 2510
.

griseofulvin

5.

7.

flocculation

( randomized cross)

8.

Aspirin

sedimentation ratio 0.60

. sedimentation ratio

. folic acid

. sedimentation ratio

. vitamin B 12

. ferrous gluconate

. sedimentation ratio

9. Cloxacillin sodium

.
. ferrous sulfate folic acid

12.

. G6PD

. aplastic anemia

for oral solution

. hemolytic anemia

sig. 1 tsp. qid ac & hs

. pernicious anemia

use)

. iron deficiency failure

. ( ready to
.

. 1

2 12

11.

. chronic renal failure

13.

. platelet

. folic acid

. vitamin B12
. ferrous sulfate

. packed red cell

14.

. aspirin
. Vit. c

. amoxy

. Amitryptyline

.
15 -18

19.
.

20.

.
.

21.

. Ginkgo , Tanakan

. chitosan

. hydroxyl citric acid

. medium chain triglyceride oil
. conjugated linoleic acid

22.

.
. dosage form
.

. 13

23.
145 .
61 . (BMI)
. 26
. 27
. 28
. 29

. 30

24.

Phentermine

.
.
.

25. phentermine

. conjugated linoleic acid

. chitosan

. hydroxyl citric acid

. Catechin

29.
dietary fiber
. chitosan

. evening primrose oil

. collagen

. Lecitin

.
.

. conjugated linoleic acid

tablet

26.

phentermine

1.

2.

3.
4. thermogenesis

27. phentermine

37.5 mg

Tapioca starch, confectionness sugar 8%

PVP in 50% ethanol , magnesium

stearate, colloidal silicon dioxide,flavors and

colors

30.

. Tapioca starch

. Confectionness sugar

28.

. Sodium starch glycolate

. colloidal silicon dioxide

. magnesium stearate

4 28

31.

.
. steroid

.
.

.
32.

.
.

.
5 57
stable angina 2

.. 2542

Acute myocardial
infraction (AMI)

Atenolol 50 mg PO OD
Ramipril 10 mg PO OD

Clopidogrel 75 mg PO OD

. antibiotic

33-38

Isotretinoin

. Vitamin A

. Drug of choice

.
. serum triglyceride

40.

systemic antibiotic

39.

Isotretinoin 0.05%

Aspirin (ASA) 51 mg PO OD
SL Isosorbide dinitrate (ISDN) 5 mg Prn

6
TC

250 mg/dl

TG
41.

245 mg/dl

.
Simvastation 20
mg flollow up

. 1

.
Niacin 1gm BID
follow up 6

.
Cholestyramine 4
gm BID

.
Gentibozil 600

45.

Sublingual

mg BID

isosorbide dinitrete

(Rhabdo)

42.

statin
. genfibrozil
propanolol
. Niacin

.
. enalapril

. cholertyramine

43.

. Atenolol

. Ramipril hypokalemia

. Cholestyramine
. Gentibrosil (blurred vision)
. Isosorbide mononitrate
44.

Atenolol

.
.
.

2

46.
isosorbide

mononitrate 20 mg.

. 2

( - block)

. 2 - (3

. heart rate

cardiac output

. heart rate

. 2
-

cardiac output

. 2 -

. heart rate

. 2 - (3 )

cardiac output

. rennin

47.

. negative feedback

. Atenolol

compensatory outflow

AMI intrinsic

sympathomimetic activity

. Ramipril

. Structure ( oxide

heart failure

nitrogen

stroke

. Clopidogrel
Platelet glycoprotein I receptor
antagonist

. alcohol

50. Angiotensin-converting enzyme

(ACE) inhibitor pH

. ASA Clopidogrel

PT/ID

. ISDN Myocardial oxygen

. Soft elastic capsule

demand HR BP
48.

. Enteric coating tublet

. Plastic natrices tablet

. Gastric floating tublet

. Methods unit tablet

Enalapril

6 20

. dissolution

. Active ingredient

51.

. (limit)

. Sinusitis

. (limit)

. Cystitis

Enalaprilat

piperazine diketone

49.

. Allergic rhinitis
. Common cold
. Bronchitis

onset duration

52.

. Volatility

. metabolisum

60

. route of administration

Pseudoephredrine

54.
ephedrine 0.5 1 drop bid

.
1

.
1

. 1

. 2

.
.

.
.
53.

2 -
2 -

1 2 -

55.

ephedrine

ephedrine
Pseudoephedrine

. hypertension
. hyperglycemia

. rebound congestion
. insomnia

. 1,2
. 1,3

. 2,3
2,4

. 3,4

56.
. Preservative

. Coloring agent
. Buffering agent
. Antioxidant

. Toxicity adjusting agent

57. ephedrine 0.5%

ephedrine 1.0%

1 . ephedrine 1.0% 2.5 ml ml

2.5 ml

. ephedrine 1.0% 2.5 ml

NSS 5 ml

. ephedrine 1.0% 2.5 ml

acetate buffer 2.5 ml

. ephedrine 1.0% 2.5 ml

5 ml

. ephedrine 1.0% 2.5 ml

NSS 5 ml

58.

.
.

.
60.

.
.

.
.

30

2-3

. Cofeed (Diphenhydramine and

. Terco-D (Dextromethrophan and

. Godlpect (Codeine phosphate and

(. 1)
60 ml

120 ml

ammonium chloride
terpin hydrate)

glyceryl guaicolate

59.

.
.

2-3

61.

Aluminium hydroxide

64.

Magnesium

(rheology)

. 1 .

..............

62.
.
. 10
. -

.
.
.
.
.
65.

20

(Sedimentation rate)

10

. Cimetidine 200 mg
. 100
.63.

.
.

. (Surfactant)

Aluminum hydroxide gel

methylcellulose

USP 26 Aluminum hydroxide

HCl

0.05 M

disodium

ethylendiamine

(diNaEDTA)

dithis..

Alcohol
TS

0.05 M Zn SO4

66.

69.

. Lupeol

. redox direct titration

. Curcumin

. Precipitation back titration

. andrographolide

. acid-base back titration

. Complexation back titration
. Diazotization direct titration

67.

68.

. Stignasterol
. hydroxyanthracens
70.

H2-blocker

. 8-12

wk.

.
duodenal ulcer
gastric ulcer

.
H. pytori

. prototype

73.

29

1-2

30

3-4

71.

. T

.
1-2
.
.
. 6
74. Ergothamine
. Alkaloids

. Flavonoids
. Phenolics
. Tannins

. Terpenoids

. C

75.

. T

erythomycin

. Migraine
. M
72.

ergotamine

. Methylergotamine

. Absorption

. Amitriptyhline

. Distribution

. Sunatriptane
. Naproxen

. Verapamil

ergotamine
Caffeine 100 mg .

. Biotransformation

76.
ergotamine
. HPLC

. Ultra-Violet spectophotometry

. Potentiometry

. 6

. fluorometry

. Polamography
77.

. 2-3 /

.
80.

. Amitriptyline

. 12 .

. Propranolol

.
55

. Fluoxetine
. Ketotifen

9 58

78.

BMI = 28 kg/m

(1)glibenclamide tablet (5) 1x2 AC

. Ergotamine

(3)Isoserbide mononitrate tablet (20) 1x2

. Propranolol

(4)Aspirin tablet (300) 1x1 PC

. Indomethacin
. Sumatriptan
. Verapamil

79.

. 6

(2)metformin tablet (500) 1x3 AC

AC

81.
DM
.

.
.

. desensitization of sulfonylureas

82.

. glibenclamide
30

. aspirin

receptor

. up-regulation of sulfonylureas receptor

. down-regulation of sulfonylureas

receptor

. hyperinsulinemia

. increase insulin sensitivity

86.

glibenclamide weight

. metforin

aspirin

. alcohol

metformin

gain

.
glibenclamine

83.
Metformin

glaucoma

.

.
.
isosorbide mononitrate

Metformin

glibenclamide

. rosiglitazone

. glucoside

. Chlorpropamide
84.
glibenclamide

.


87. 10
uniformity

125 mg. S

. glucagon

(Sample standard deviation) RSD (relative

. Insulin

. 2%

. Insulin
. somatostatin
85.
Glibenstermine

standard deviation)
. 3%
. 4%
. 5%

. 6%
88. aspirin

1
0

Ethinyl

estradiol 30 g + Levonorgestrel 0.15 mg

. faking

. picking

. paling

. mottling
. capping

89. .
.
.
.

.
.

90. glibenclamide

5 18.00 .

2

91.
. Lynestrenol

. Levonorgestrel
. Ethinyl estradiol + Levonorgestrel
. Ethinyl estradiol + Desogestrol
. Ethinyl estradiol + Gestodene

92.

. polarized

. HPLC-

UV detection

2 30 + 2

.

. Ethinyl estradiol 2.5 mg 2

3

. Levonorgestrel 0.75 mg 2
12 .

. Ethinyl estradiol 50 g +

Levonorgestrel 0.25 mg2

12 .

Levonorgestrel 17

.
.

500

00

94. Labeled amount Levonorgestrel

. 98.8
. 99.8

. 100.8
. 101.8

. 102.8

95.
Levonorgestrel

. Identification IR
spectorphotometry

. Specific rotation

. Related substance
. Loss on drying

Levonorgestrel

0.75 mg 20

HPLC

Levonorgestrel 0.15
mcg/ml
3

500

. UV analysis

000

93.

le

avar

age

d
5

stand 125

124

124

124

ard

000

000

500

500

samp 128

128

127

128

96.
dose
. wet granulation

. dry granulation
. direct compression

. wet dry granulation

. wet granulation direct
compression

97. Ethinyl estradiol

. rifampin
5

.
corticosteroid

. Norethindrone

progestins

effect

. Lynestrenol androgenic effect

. C=CH 2

+ Levonorgestrel

ketone

.
barbiturate
. phenyltoin
. aspirin
98. Ethinyl estradiol

. Norethindrone androgenic
Testosterone

Norethindrone

oxidation OH

. Ethinyl estradiol

100. ... .. 2510

estrogen

. Levonorgestrel
progestins

. Ethinyl estradiol 0.03 mg

+ Levonorgestrel 0.15 mg
biphasic combination
2

1.
1.
2.

3.

over the counter

4.

. Levonorgestrel

11 27

. Levonorgestrel isomer

Ethinyl estradiol
Norgestrel

99. 2
- Lynestrenol

Norethindrone

. Lynestrenol estrogen

2-3

paracetamol Ibuprofen 20

Paracet

1-2 4-6
Ibuprofen 1
3

101.

104. Ibuprofen

Primary dysmenorrhea

1 .

1.
27

2. 1. mefenamic acid
3. .

2.

hyoscine-n-butylbomide

4. 2-3 3. estradiol+ levonorgertrel

4. orphenadine

5. 5. tolperisone

paracet Ibuprofen

105.

102.

.

1. aspirine

2.

colcicine

3.

naproxen

4.

celecoxib

5.

Ibuprofen

mefenamic acid
106. major metabolite

paracetamol

Ibuprofen

Ibuprofen

103. Ibuprofen

107.

1. Serotonin
2. Prostaglandin

3. Cycloxygenase
4. Leukotriene

5. thromboxane

1.
2.

4.

3.

5.

108.
Ibuprofen

1. 2
2.

3.

4.

3.

4.

5.

12 8

..

1
para syrup

amoxicillin dry powder 3

109. Paracet

..

1. punch (deep

..

concave punch )

2. die

3.
4. hygroscopic

111.

1.

2.

4.

5.

110. Ibuprofen

3.

5.

1.
2.

..

..

DTP MMR

1 ..

112. .. /

1.

114.

2.

3.
4.
5.

113. ..

1.

2.

1.

2.

3.
..

4.

5.

115. DTP MMR Vaccine

1. DTP vaccine

MMR vaccine

2. DTP vaccine

..

..

.. 9
..
9

MMR vaccine
/

3. DTP vaccine inactivated

vaccine MMR liveattenuated vaccine

4. DTP vaccine toxoid

MMR vaccine subunit

1. Chlorphenimine maleate tablet

2. Hydroxyzine HCI tablet
3.

Neomycin/bacitracin ointment

4. Calamine lotion

5. Prednisolone cream

vaccine

120.

MMR vaccine toxoid

5. DTP vaccine subunit vaccine

116.

117.

live-attenuated vaccine 1. Cost Minimization Analysis

1.

2.
3.

2.

Cost Effectiveness Analysis

3. Cost benefit Analysis

4. Cost Utility Analysis
5. Cost outcome

Description

4.

13 22

5.

118.

1.
2.

75 kg. 155 cm

3.

4.

5.

119. .. 4

..

Diclofenac gel

..

121.

124.

diclofinac emulsion

gel

1. glucosamine sulfate

1.

3. aruanofin

3.

5.

5.

2. hydroxychloroquine
4. Prednisolone
methotrexate

122.

2.
4.

1.

2.

3.

125.
126.

1.

opioid analgesic
NSAIDs

4.

2. opioid

5. codeine para

3. NSAIDs

123.
diclofinac emulsion gel

1. carbopol

2. preservative

analgesic

4. opioid

analgesic

5. cox-2

cox-1

127.

cox-2 selective inhibitor

3.

freeze- cycle

4. emulsion gel

cream

5. emulfying agent

cox-2 selective inhibitor

1. Cox-2 inhibitor

Carboxyl group
enzyme cox-2

2. cox-2 inhibitor

cox-2

130.
...
2510

1. Diclofenac tab 25 mg

cox-2/cox-1 Selective ratio

2. Piroxicam cap 10 mg

3. cox-2 inhibitor

4. cox-2 inhibitor

sulfonamide

5. cox-2 inhibitor
Cox-2
cox-1

128. Diclofenac pKa = 4.5

(pH=1) .
1000/1
100/1
1/1

3. Tolperisone 50 mg

Diclofenac 25 mg
1

4. Piroxicim 20mg

5. Rofecoxib 25 mg

1/1000

14

1/100

Diclofenac injection 75 mg/3 ml

Methadone tablet 10 mg

Rofecoxib tab 25 mg

129.

Dexanethasone injection

Prednisolone tab 5 mg

131.

132.

7% Atropine sulfate solution

0.9 % NaCl

1.

Atropine sulfate

2.

steroid

4.

Atropine

NaCl

8.3 g

3.

0.5 g

100 ml

H2O

1. Hypotonic solution

2. Hypertonic solution

5. ( 3. Isotonic solution
) 4. Atropine sulfate

136.

133.

aqueos humer

1. Solution

Pilocarpine

3. Ointment

Thiazide

5. Ocular insert

1. Timolol
.
.

Mannitol

Carbachol

2. Suspension
4. Cream

134.

1.

0.1% Diclofinac ED.

2. 0.1% Fluorometholone ED
3.

0.1% Dexamethasone ED

4. 0.5% Atropine ED

5. 0.05% Naphazoline ED

135. 0.5 % Atropine ED

137.

1. 170

C 2 .

2.
3. sterile

membrane

4. LAL test

5. E.coli 10 cfc/ml

138.

139.

Liquid paraffin ( HLB for o/w)

5.0

1. 24 .

Tween 80 ( HLB for o/w)

2. 5

2.5

4. 1

3. 7
5. 3

140.

1. Diclofenac ED

2. Chloramphenicol eye ointment

141.

1. Breaking

3. Timolol ED

2. Cracking

5. Tetracycline eye ointment\

4. Phase inversion

4. Dexamethazone ED
15


triamcinolone 0. %

% by weight
Triamcinolone acetonide

3. Caping

5. Phase seperation
142.
1.

2.

3.
4. (emulsifier)

5.

0.1

143. required HLB o/w

Lanolin ( HLB for o/w)

emulsion stearic acid

1.0

liquid paraffin

Stearic acid ( HLB for o/w)

1. 9.5

Propylene glycol

3. 11.04

2.0
8.0

2. 10.75
4. 12.13

5. 14.0
144.

C. Triamcinolone 0.1%
D. Betametasone cream

o/w

B>D>C>A

1. Tween 80 : Span 80 = 8.43 : 2.87

D>A>C>B

3. Tween 80 : Span 80 = 15.0 : 3.7

C>D>A>B

2. Tween 80 : Span 80 = 2.87 : 8.43

4. Tween 80 : Span 80 = 3.7 : 15.0
5.

A>D>B>C
D>B>C>A

Tween 80 : Span 80 = 1.5 : 2.5

147.

o/w

conjugated 3- ketone (b)11-OH group

145.
1.

( emulsifier system) HLB

glucocorticoids .....
(c)17 B ketol side chain
acetonide 16
17

2.

( emulsifier system) HLB

3.

( emulsifier system) HLB

4.

( emulsifier system) HLB

5.

( emulsifier system) HLB

146. steroid

A. Hydrocortisone cream 2.5%

B. Clobatasol ointment 0.05 %

triamcinolone acetonide
1.

steroid

2. receptor van der

waal force

3.

lipophilicity

4.

hydrophiliciy

5. sodium retention

148. triamcinolone
acetonide HPLC

internal standard fluoxymesterone 2.

peak triamcinolone 3.
peak fluoxymesterone

4.

chromatogram

5.

peak

1.

flow rate

2.

injection volume

3.

column

4.

guard column system

5.

mobile phase
149.

1.

49( 1)

1 Ishmic Hearth Disease

HTN 5

HCTZ + Metoprolol
Lab BP 125/85 BUN Scr

1. Metoprolol

- heart attack

triamcinolone lotion

2. Metoprolol 5

triamcinolone lotion

3.
heart

2.
3.

triamcinolone lotion

4.

triamcinolone lotion

5.

attack

- NTG
4. NTG

5.

NTG

1. ASSAY

150. triamcinolone

2. Disolution

4. Uniformity

cream 0.1 % 15 g
1.

3. Dissintigration

6.

2 Asthma

Salbutamol MDI PRN

1.

- GINA (
)

2.

- Oral thrush
6. Prednisolone

- special control

7.
- spacer (
)

8. MDI DPI

(dry powder inhaler)

- Turbuhaler

9. Evohaler

1.

3 Glaucoma

3.

2.
4.
5.

3. 2

- steroid

4.

Betaxolol

1.
- Decrease aqueous humor production

2. -

Atropine

3.

- Hyoscine

4.

5.

- long acting Beta2 agonist (

6.

7. Compliance

5.

8. .

9.

1.

2.
3.

4.
5.

4 Otitis Media
6

1. - Strep

pneumo.

2.
First

choice

- Amoxycillin

3. -

Erythromycin

4.

6.

pseudoephedrine

7. Pseudoephedine

- P2

8. -

..

9. pseudoephedrine

10. 3

% LA

5 Anxiety / Depression

1. -

1 .
2. -

Zolpidem

3.

- Amitriptyline

- Purified water

4. -

5.

5. Preservative

- Paraben

Sertaline

6. fluoxetine

5.

7. -

6 Parkisonism

?
levodopa/Carbidopa

4. Progestogen

Ibuprofen 400 mg

MTV

1.

6.

8 Primary dysmennrhea +

+
5

Levodopa/Carbidopa

1.

2.

2. On Off

3.

4. Psychosis

MTV

5.

SAR

7 Oral Contraceptives

1. Phyto

Estrogen

2. 3

3. EE

3.

4. Displcement

Value = 2 1
20

5.
-

6.

9 Cysitis
1.

2.

3. Norfloxacin
4. 1 gr / 2 flz

5.
-

10 Gout

20

Lab
gout

1.

1.
2.

2. Colchicine

3.
1

6. Colchicine

7. Colchicine

8. K Shelf-

life

- 0.104/K

11 Diabetes Miletus

3.

4.

Type II

5.

2 Insulin

2. gout attack -

3.

Allopurinol

- Low dose aspirin

NSAIDs Para

4.

5.

1. Para inhibit COX

1. -

hypoglycemia

2. - Glucose
3. Shift electron

Chlopropamide

Tolbutamide

4. Insulin -

5. Insulin

14. Thiazolididione

Glucagon

6. NPH

7. Insulin
8. Sulfonylurea

- Hepatotoxicity
15.

12 Peptic Ulcer

3-5

1. Antacid

Sulfonylurea

2.

9.

- Glipizide
Glipizide!?

10. Glipizide

1. Sulfonylurea----

2. Sulfone

11.

- 7
-

3.
-

4. Antacid

5. GU, DU

6.

Scr

7. H2 Block

8.

12.

13. Thiazolidinedione

Type I

Triple therapy

- 3

9.
- curcumin

10.

13 Hypersensitivity

1. Type

2.
- Hydroxyzine 10

mg 1 x 3

3.
-

4.

5.

6.

7.

14 Vitamin A Deficiency

3.
-

4.

- Cholestyramine
5. Cod liver oil

6. Preservative

7.

8. % RDA

RDA -

15 Vaccine and Biologics

1.

5-6

1.

Immunoglobulin

Immunoglobulin

2.

-

tetanus

2.

3.
Imunoglobulin

- Active
HMI

49( 2)

1 Heart Failure

4. - 5

HF HCTZ

1.

2. HCTZ - Gout

5. 2

-

3. Cross allergy Sulfa

HCTZ

4.

6. 5 6

5. HCTZ

7.
8.

Dry freeze

9. Pka

Pka
pH .

6.

HCTZ

7. 25 mg

1 1
- 30

2 Hyperlipidemia

Lab

LDL +
Lab 7-8
1.

- atorvastatin

Lab

2.

Prodrug

3. Statin

- hepatotoxic

Lab

aminotransferrase

4. -

Gemfibrozil

4. -

Diclofenac

5.
6.

7. -

8. -

5 HRT

5. Guideline

1.

6. -

2.

7.

3.

- CUA

vasomotor symptom

EE

3 DM

6 Osteoartritis

40 40

Renal

Diclofenac

1.

2.

3. Diclofenac -

Glucosamine

1.

2. OA

- --- , ,

3. / OA


4. Glucosamine
5. Glucosamine

6. Calcium carbonate xx mg /

tab calcium
yyy mg

7. Calcium
8. specific cox 2

7 Opportunistic Infections

hiv +ve , CD4 cout 154

1. -

2. -

pessaries

3. - PEG

5. 5

6. Ketoconazole

- CMA

7. pKa pH %

+ Lab + +BSA

1. BSA
2. BSA

10 Pregnancy
1. Isotretinoin cat - X

2. - teratogenic

3. Insulin

4. Prophylaxis OIs

4.

6. CI 1

5.

5.
significant

11 Allergy

1.

2. - ketoconazole
3. - 200 mg OD

4. Ketoconazole

1. Mediator

2.

3. -

CPM

4.
- 4
Low

5.
3

6.
7. Cetyl

acohol

12 Migraine

1.

- Rofecoxib

2.

15 Diarrhea
2

1. - Loperamide

2.

3. 5 - anova

Article 1.

3. Ergotamine

1. Thiethanolamine

4. Ergotamine

3. Rx

5.

13 Bacteria Pharyngitis

Amoxy

1. -

2.
3. Rhinitis medicament

4. 4 -

14 Bacteria conjunctivitis
1.

2.
3. meq/L

2. Zeta Potential

0.5 ml E = 0.23, NaCl

x ml

E = 0.1, q.s water 100 ml, Mft ad 30 ml

X

4. NaCl 0.45 % 500 ml

meq

5.

6.

7. Theobroma oil

8.

9. 8 Assay .

3.
vac.

1.

4. DTP

( 40 )

vac.

2. Science

5. pt. rabies

Care

vac.

3.

choice

4. Law

5. Econ 2 Epidermio 1

2. + tetanus

Research 1

3. + rabies

6. medchem assay

1. + betadine

6.

vac.

Case 3 Migraine

1. (

case with or without aura)

50 ( 1)
Case 1

PU
vaccine

1. vac.
.......
2.
vac.

pt.

1. cisapride

Case 2

Case

(BCG)

metoclopramide + Ibuprofen
2. metoclopramide

3.

Case 4

prerenal, intrinsic

Cystitis

Pt.

BUN/Scr >20:1 )

2. lab

hypokalemia ,

1.

azotemia

3.

(poly / oligo / normal/ anuria/

2. pt.

.)

Pt.
1

3.

4.
pt.

urine

Case 7 Bacterial conjunctivitis

1. isotonic

2. isotonic

5.

capsule

hypo / hyper / isotonic

RBC

Case 5 Cancer

Case 8 Acne case

Pt. CHOP regimen

Case 9 Asthma

, . pt.

s/e

Case 11 DM 2

Case 12 Ishemic heart disease

Case 6 renal
Pt. lab (

urine)

1.

Case 10 Allergic rhinitis

Case 13 Hyperlipidemia (

)

Case 14 NSAIDs
Case 15 + HRT


50 ( 2)

3.

GI

4.

Case 1

1.

choice

5. .

2.

KMnO4

3.
pt.

( case)

6.

4. DV

5. Pt.

15 3

1.
Pco

2.

Case 2 Hypothyroid
Lab
FT4 TSH
1.

2. /

(Myxo)

3.

(Hashimoto.)

4. drug of choice

(levothyroxine)

5.

receptor

(I

D L DL
form)

6.

(

T3 3
5 .......)
7.

choice
therapy

TSH 46 )

Case 3 Glaucoma

Pt.


1. pt.

2.
pt.

3. /

( )

( 3-4 )

fluoxetine /

amitrip.

pt.

1.

2. (

)

3. SSRIs ..............

4.

(
fluoxetine
MCQ & OSPE )

Case 5 Toxicology

4. pt.

Pt.

5. sterile

para.

6.
...........

7. , pKa

1.

2. Antidote

atropine, atropine sulfate

3. func. Group

4.

(

pH /
pKa )

Case 4 Depression

antidote

( effervescent
)

5. Dead mixture

Case 6 DM + hyperlipidemia

1. pt.
2

........

2.

2. NPH

1.

3. pt.

2.

intermediate

3. Emulsifier

Case 7 HIV + TB

Pt.

1. Opportunistic infection

2.

CD4/ CD8

????

3.
metabolic

( PIs)
abacarvir NRTIs

Case 8

1. Calamine

lotion

4. flocculating

5.

Case 9 /

Case 10 Traveler diarrhea (

, )
Case 11 HRT

Case 12 HTN

Case 13 RA + OA
Case 14 Sinusitis
Case 15 URI

Ospe


2551

3-4

(
49 3),

HIV TB, OIs

( 50 2

7)

MCQ